Rafferty Asset Management
IMNM icon

Rafferty Asset Management’s Immunome IMNM Stock Holding History

Rafferty Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Sell
83,170
-73,050
-47% -$1.56M ﹤0.01% 674
2026
Q1 		$3.42M Buy
156,220
+42,825
+38% +$953K 0.01% 494
2025
Q4 		$2.44M Buy
113,395
+26,905
+31% +$472K 0.01% 606
2025
Q3 		$1.01M Buy
86,490
+10,088
+13% +$100K ﹤0.01% 788
2025
Q2 		$711K Sell
76,402
-26,073
-25% -$214K ﹤0.01% 816
2025
Q1 		$690K Buy
102,475
+21,084
+26% +$202K ﹤0.01% 813
2024
Q4 		$864K Sell
81,391
-5,698
-7% -$68.9K ﹤0.01% 819
2024
Q3 		$1.27M Sell
87,089
-28,956
-25% -$411K ﹤0.01% 749
2024
Q2 		$1.4M Buy
+116,045
New +$1.82M 0.01% 739

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Rafferty Asset Management's IMNM Position: Q2 2026 in Review

Rafferty Asset Management reduced its Immunome (IMNM) stake by 47% in Q2 2026, selling an estimated $1.56M and leaving 83,170 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #674.

Rafferty Asset Management first reported a position in IMNM in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.42M in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Rafferty Asset Management held 83,170 shares of Immunome worth $1.76M as of Q2 2026.
  • Rafferty Asset Management sold 73,050 Immunome shares in Q2 2026, an estimated $1.56M.
  • Immunome made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #674 holding.
  • Rafferty Asset Management first reported a position in Immunome in Q2 2024 and has held it in 9 quarters since.
  • Rafferty Asset Management's Immunome position peaked at $3.42M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.